• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION V-18 GUIDEWIRE; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION V-18 GUIDEWIRE; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Patient Problems Hemoptysis (1887); Cardiac Perforation (2513); Thrombosis/Thrombus (4440)
Event Date 02/12/2024
Event Type  Injury  
Event Description
It was reported that one hour post cardiomems implant procedure the patient experienced hemoptysis.The patient was intubated and a bronchoscopy was performed which identified a clot at the site of perforation.The hemoptysis resolved without further intervention.The patient was hospitalized over night.The site did not treat the perforation or clot.The patient is currently fully recovered and has been discharged.The physician reported the likely cause of the perforation was the boston scientific v-18 wire."this report reflects information received by fda in the form of a notification per 803.22 (b)(2)".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
V-18 GUIDEWIRE
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
MDR Report Key19194138
MDR Text Key341323719
Report NumberMW5154364
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/25/2024
Patient Sequence Number1
-
-